| Product name | Wogonin | Manufacture date | Mar.07.2025 |
| Batch number | SW250307 | Analysis date | Mar.08.2025 |
| Batch quantity | 300kg | Expire date | Mar.07.2027 |
| Item | Specification | Results |
| Appearance | yellow powder | Conforms |
| Assay | 99% | Conforms |
| Heavy metal | ≤10ppm | Conforms |
| Lead | ≤2.0ppm | Conforms |
| As | ≤2.0ppm | Conforms |
| Ca | ≤1.0ppm | Conforms |
| Me | ≤0.1ppm | Conforms |
| Total aerobic microbial count | ≤1000CFU/g | Conforms |
| Total moulds&yeast count | ≤100CFU/g | Conforms |
| Enterobacterial | ≤10MPN/g | Conforms |
| Salmonella | N.D/25g | Conforms |
| Escherichia coli | N.D/10g | Conforms |
| Staphylococcus aureus | N.D/10g | Conforms |
| Pseudomonas aeruginosa | N.D/10g | Conforms |
| Conclusion: C onform with specification. | ||
| Packing description: | Sealed export grade drum & double of sealed plastic bag |
| Storage: | Store in a tightly closed container ,in a cool and dry place |
| Shelf life: | 2 years when properly stored |
1.
Wogonin
be used for the treatment of paralysis after cerebrovascular disease;
2.
Wogonin
can remove oxygen free radicals, but also inhibit the melanin formation;
3.
Wogonin
will reduce cerebral vascular resistance, improve blood circulation, increase cerebral blood flow and has anti-platelet aggregation effect;
4.
Wogonin
has antibacterial, diuretic, anti-inflammatory, anti metamorphosis and antispasmodic effect,and has strong anti-cancer response to physiological performance
.
| Similiar product recommendation | |||
| Catuaba Extract | Cistanche Extract | Yohimbine Hcl | |
| Silybum Marianum | Roselle | Bitter Bean Extract | Kava Extract |
| Tongkat Ali Extract | Tribulus Terrestris Extract | Maca Extract | Leek Seed Extract |
| Cynomorium Extract | Cistanche Extract | Wolfberry Extract | Allicin |
1. Customs clearance